These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23778562)

  • 41. Medical and surgical strategies for treating urogynecological disorders.
    Samsioe G
    Int J Fertil Menopausal Stud; 1996; 41(2):136-41. PubMed ID: 8829692
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Urinary incontinence and menopause].
    Legendre G; Fritel X; Ringa V; Lesavre M; Fernandez H
    Prog Urol; 2012 Oct; 22(11):615-21. PubMed ID: 22999085
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A surprisingly low prevalence of demonstrable stress urinary incontinence and pelvic organ prolapse in women with multiple sclerosis followed at a tertiary neurogenic bladder clinic.
    Dillon BE; Seideman CA; Lee D; Greenberg B; Frohman EM; Lemack GE
    J Urol; 2013 Mar; 189(3):976-9. PubMed ID: 23022010
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The prevalence of urogenital symptoms in postmenopausal women.
    Stenberg A; Heimer G; Ulmsten U
    Maturitas; 1995 Dec; 22 Suppl():S17-S20. PubMed ID: 8775772
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vasomotor symptoms and urogenital atrophy in older women: a systematic review.
    Zeleke BM; Davis SR; Fradkin P; Bell RJ
    Climacteric; 2015 Apr; 18(2):112-20. PubMed ID: 25382674
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of menopausal symptoms in breast cancer patients.
    Loibl S; Lintermans A; Dieudonné AS; Neven P
    Maturitas; 2011 Feb; 68(2):148-54. PubMed ID: 21185135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hormonal influence on the urinary tract.
    Klutke JJ; Bergman A
    Urol Clin North Am; 1995 Aug; 22(3):629-39. PubMed ID: 7645161
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Urogenital estrogen deficiency symptoms. Too few elderly women receive any treatment].
    Lisper B; Nordenstam I; Wessling A
    Lakartidningen; 1993 Dec; 90(49):4451-2. PubMed ID: 8271889
    [No Abstract]   [Full Text] [Related]  

  • 49. Urogenital symptoms and resulting discomfort in non-institutionalized Dutch women aged 50-75 years.
    van Geelen JM; van de Weijer PH; Arnolds HT
    Int Urogynecol J Pelvic Floor Dysfunct; 2000; 11(1):9-14. PubMed ID: 10738928
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estrogen in urinary incontinence treatment: an anatomic and physiologic approach.
    Maloney C
    Urol Nurs; 1997 Sep; 17(3):88-91. PubMed ID: 9349042
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The prevalence and factors associated with previous surgery for pelvic organ prolapse and/or urinary incontinence in a cross-sectional study in The Netherlands.
    de Boer TA; Slieker-Ten Hove MC; Burger CW; Kluivers KB; Vierhout ME
    Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):343-9. PubMed ID: 21664028
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urogynecological effects of menopause.
    Bulchandani S; Toozs-Hobson P
    Expert Rev Endocrinol Metab; 2014 Jan; 9(1):73-77. PubMed ID: 30743740
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Approach to urinary tract disorders in postmenopausal women].
    Fernandes CE; Morita MH; Ferreira JA; da Silva EP; Wehba S
    Rev Paul Med; 1990; 108(5):230-5. PubMed ID: 2103063
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sex hormones, the menopause and urinary problems.
    Cardozo LD; Kelleher CJ
    Gynecol Endocrinol; 1995 Mar; 9(1):75-84. PubMed ID: 7793304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genitourinary Syndrome Of Menopause and Vaginal Estrogen Use.
    Steele NM; Ledbetter CA; Bernier F
    Urol Nurs; 2016; 36(2):59-65, 71. PubMed ID: 27281861
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative controlled trial of a novel oral estrogen therapy, estradiol acetate, for relief of menopause symptoms.
    Utian WH; Speroff L; Ellman H; Dart C
    Menopause; 2005; 12(6):708-15. PubMed ID: 16278614
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Epidemiology and treatment for urinary incontinence and pelvic organ prolapse in women].
    Starczewski A; Brodowska A; Brodowski J
    Pol Merkur Lekarski; 2008 Jul; 25(145):74-6. PubMed ID: 18839620
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estrogen therapy in older patients with recurrent urinary tract infections: a review.
    Rozenberg S; Pastijn A; Gevers R; Murillo D
    Int J Fertil Womens Med; 2004; 49(2):71-4. PubMed ID: 15188831
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of a new, oral estradiol acetate formulation for relief of menopause symptoms.
    Speroff L; Haney AF; Gilbert RD; Ellman H;
    Menopause; 2006; 13(3):442-50. PubMed ID: 16735941
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Midterm prospective comparison of vaginal repair with mesh vs Prolift system devices for prolapse.
    Chen YS; Cao Q; Ding JX; Hu CD; Feng WW; Hua KQ
    Eur J Obstet Gynecol Reprod Biol; 2012 Oct; 164(2):221-6. PubMed ID: 22771224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.